Matrix Metalloproteinase-9 Inhibition Improves Proliferation and Engraftment of Myogenic Cells in Dystrophic Muscle of mdx Mice

PLoS ONE

Volumn 8, Issue 8, 2013, Pages

  Hindi, Sajedah M ^a   Shin, Jonghyun ^a   Ogura, Yuji ^a   Li, Hong ^a   Kumar, Ashok ^a  

^a University of Louisville School of Medicine   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GELATINASE B; NOTCH RECEPTOR; WNT PROTEIN; MATRIX METALLOPROTEINASE INHIBITOR; MMP9 PROTEIN, MOUSE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL PROLIFERATION; CONTROLLED STUDY; DISEASE MODEL; DUCHENNE MUSCULAR DYSTROPHY; ENGRAFTMENT; ENZYME INHIBITION; GENE EXPRESSION REGULATION; GENE TARGETING; M1 MACROPHAGE; M2 MACROPHAGE; MACROPHAGE; MOUSE; MUSCLE DEVELOPMENT; MYOBLAST; NONHUMAN; PROTEIN EXPRESSION; SATELLITE CELL; SIGNAL TRANSDUCTION; SKELETAL MUSCLE; ANIMAL; C57BL MOUSE; CELL CULTURE; DRUG EFFECTS; ENZYMOLOGY; GRAFT SURVIVAL; KNOCKOUT MOUSE; METABOLISM; MUSCULAR DYSTROPHY, DUCHENNE; PATHOLOGY; PHENOTYPE; PRIMARY CELL CULTURE; TRANSPLANTATION; WNT SIGNALING PATHWAY; X CHROMOSOME LINKED MUSCULAR DYSTROPHIC MOUSE;

ANGIOSTRONGYLUS CANTONENSIS; ANIMALS; BRAIN; CEREBROSPINAL FLUID; CLAUDIN-5; DIPEPTIDES; DISEASE MODELS, ANIMAL; EOSINOPHILS; LEUPEPTINS; MALE; MATRIX METALLOPROTEINASE 9; MENINGOENCEPHALITIS; MICE; MODELS, BIOLOGICAL; NF-KAPPA B; PROTEOLYSIS; SIGNAL TRANSDUCTION; STRONGYLIDA INFECTIONS; CELL PROLIFERATION; CELLS, CULTURED; GRAFT SURVIVAL; MACROPHAGES; MATRIX METALLOPROTEINASE INHIBITORS; MICE, INBRED C57BL; MICE, INBRED MDX; MICE, KNOCKOUT; MUSCLE, SKELETAL; MUSCULAR DYSTROPHY, DUCHENNE; MYOBLASTS; PHENOTYPE; PRIMARY CELL CULTURE; RECEPTORS, NOTCH; WNT SIGNALING PATHWAY;

EID: 84881594834     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0072121     Document Type: Article

References (66)

1. Cohn RD, Campbell KP, (2000) Molecular basis of muscular dystrophies. Muscle Nerve 23: 1456-1471.
2. Dalkilic I, Kunkel LM, (2003) Muscular dystrophies: genes to pathogenesis. 13: 231-238.
3. Emery AE (2002) The muscular dystrophies. Lancet 359 687-695.
4. Page-McCaw A, Ewald AJ, Werb Z, (2007) Matrix metalloproteinases and the regulation of tissue remodelling. Nat Rev Mol Cell Biol 8: 221-233.
5. Vu TH, Werb Z, (2000) Matrix metalloproteinases: effectors of development and normal physiology. Genes Dev 14: 2123-2133.
6. Kherif S, Lafuma C, Dehaupas M, Lachkar S, Fournier JG, et al. (1999) Expression of matrix metalloproteinases 2 and 9 in regenerating skeletal muscle: a study in experimentally injured and mdx muscles. Dev Biol 205: 158-170.
7. Kumar A, Bhatnagar S, Kumar A, (2010) Matrix metalloproteinase inhibitor batimastat alleviates pathology and improves skeletal muscle function in dystrophin-deficient mdx mice. Am J Pathol 177: 248-260.
8. Fukushima K, Nakamura A, Ueda H, Yuasa K, Yoshida K, et al. (2007) Activation and localization of matrix metalloproteinase-2 and-9 in the skeletal muscle of the muscular dystrophy dog (CXMDJ). BMC Musculoskelet Disord 8: 54.
9. Delfin DA, Zang KE, Schill KE, Patel NT, Janssen PM, et al. (2012) Cardiomyopathy in the dystrophin/utrophin-deficient mouse model of severe muscular dystrophy is characterized by dysregulation of matrix metalloproteinases. Neuromuscul Disord 22: 1006-1014.
10. Nadarajah VD, van Putten M, Chaouch A, Garrood P, Straub V, et al. (2011) Serum matrix metalloproteinase-9 (MMP-9) as a biomarker for monitoring disease progression in Duchenne muscular dystrophy (DMD). Neuromuscul Disord 21: 569-578.
11. Dahiya S, Bhatnagar S, Hindi SM, Jiang C, Paul PK, et al. (2011) Elevated levels of active matrix metalloproteinase-9 cause hypertrophy in skeletal muscle of normal and dystrophin-deficient mdx mice. Hum Mol Genet 20: 4345-4359.
12. Dahiya S, Givvimani S, Bhatnagar S, Qipshidze N, Tyagi SC, et al. (2011) Osteopontin-stimulated expression of matrix metalloproteinase-9 causes cardiomyopathy in the mdx model of Duchenne muscular dystrophy. J Immunol 187: 2723-2731.
13. Li H, Mittal A, Makonchuk DY, Bhatnagar S, Kumar A, (2009) Matrix Metalloproteinase-9 Inhibition Ameliorates Pathogenesis and Improves Skeletal Muscle Regeneration in Muscular Dystrophy. Hum Mol Genet 18: 2584-2598.
14. Tidball JG, Villalta SA, (2010) Regulatory interactions between muscle and the immune system during muscle regeneration. Am J Physiol Regul Integr Comp Physiol 298: R1173-1187.
15. Villalta SA, Nguyen HX, Deng B, Gotoh T, Tidball JG, (2009) Shifts in macrophage phenotypes and macrophage competition for arginine metabolism affect the severity of muscle pathology in muscular dystrophy. Hum Mol Genet 18: 482-496.
16. Javierre BM, Fernandez AF, Richter J, Al-Shahrour F, Martin-Subero JI, et al. (2010) Changes in the pattern of DNA methylation associate with twin discordance in systemic lupus erythematosus. Genome Res 20: 170-179.
17. Villalta SA, Rinaldi C, Deng B, Liu G, Fedor B, et al. (2011) Interleukin-10 reduces the pathology of mdx muscular dystrophy by deactivating M1 macrophages and modulating macrophage phenotype. Hum Mol Genet 20: 790-805.
18. Huang H, He X, (2008) Wnt/beta-catenin signaling: new (and old) players and new insights. Curr Opin Cell Biol 20: 119-125.
19. von Maltzahn J, Chang NC, Bentzinger CF, Rudnicki MA, (2012) Wnt signaling in myogenesis. Trends Cell Biol 22: 602-609.
20. Tran TH, Shi X, Zaia J, Ai X, (2012) Heparan Sulfate 6-O-endosulfatases (Sulfs) Coordinate the Wnt Signaling Pathways to Regulate Myoblast Fusion during Skeletal Muscle Regeneration. J Biol Chem 287: 32651-32664.
21. von Maltzahn J, Bentzinger CF, Rudnicki MA, (2012) Wnt7a-Fzd7 signalling directly activates the Akt/mTOR anabolic growth pathway in skeletal muscle. Nat Cell Biol 14: 186-191.
22. Kuang S, Kuroda K, Le Grand F, Rudnicki MA, (2007) Asymmetric self-renewal and commitment of satellite stem cells in muscle. Cell 129: 999-1010.
23. Kitamoto T, Hanaoka K, (2010) Notch3 null mutation in mice causes muscle hyperplasia by repetitive muscle regeneration. Stem Cells 28: 2205-2216.
24. Conboy IM, Conboy MJ, Smythe GM, Rando TA, (2003) Notch-mediated restoration of regenerative potential to aged muscle. Science 302: 1575-1577.
25. Brack AS, Conboy IM, Conboy MJ, Shen J, Rando TA, (2008) A temporal switch from notch to Wnt signaling in muscle stem cells is necessary for normal adult myogenesis. Cell Stem Cell 2: 50-59.
26. Sampaolesi M, Blot S, D'Antona G, Granger N, Tonlorenzi R, et al. (2006) Mesoangioblast stem cells ameliorate muscle function in dystrophic dogs. Nature 444: 574-579.
27. Dezawa M, Ishikawa H, Itokazu Y, Yoshihara T, Hoshino M, et al. (2005) Bone marrow stromal cells generate muscle cells and repair muscle degeneration. Science 309: 314-317.
28. Darabi R, Santos FN, Perlingeiro RC, (2008) The therapeutic potential of embryonic and adult stem cells for skeletal muscle regeneration. Stem Cell Rev 4: 217-225.
29. Partridge TA, Morgan JE, Coulton GR, Hoffman EP, Kunkel LM, (1989) Conversion of mdx myofibres from dystrophin-negative to-positive by injection of normal myoblasts. Nature 337: 176-179.
30. Cerletti M, Jurga S, Witczak CA, Hirshman MF, Shadrach JL, et al. (2008) Highly efficient, functional engraftment of skeletal muscle stem cells in dystrophic muscles. Cell 134: 37-47.
31. Qu Z, Balkir L, van Deutekom JC, Robbins PD, Pruchnic R, et al. (1998) Development of approaches to improve cell survival in myoblast transfer therapy. J Cell Biol 142: 1257-1267.
32. Srivastava AK, Qin X, Wedhas N, Arnush M, Linkhart TA, et al. (2007) Tumor necrosis factor-alpha augments matrix metalloproteinase-9 production in skeletal muscle cells through the activation of transforming growth factor-beta-activated kinase 1 (TAK1)-dependent signaling pathway. J Biol Chem 282: 35113-35124.
33. Paul PK, Gupta SK, Bhatnagar S, Panguluri SK, Darnay BG, et al. (2010) Targeted ablation of TRAF6 inhibits skeletal muscle wasting in mice. J Cell Biol 191: 1395-1411.
34. Hindi SM, Paul PK, Dahiya S, Mishra V, Bhatnagar S, et al. (2012) Reciprocal interaction between TRAF6 and notch signaling regulates adult myofiber regeneration upon injury. Mol Cell Biol 32: 4833-4845.
35. Bulfield G, Siller WG, Wight PA, Moore KJ, (1984) X chromosome-linked muscular dystrophy (mdx) in the mouse. Proc Natl Acad Sci U S A 81: 1189-1192.
36. Stedman HH, Sweeney HL, Shrager JB, Maguire HC, Panettieri RA, et al. (1991) The mdx mouse diaphragm reproduces the degenerative changes of Duchenne muscular dystrophy. Nature 352: 536-539.
37. Dangain J, Vrbova G, (1984) Muscle development in mdx mutant mice. Muscle Nerve 7: 700-704.
38. DiMario JX, Uzman A, Strohman RC, (1991) Fiber regeneration is not persistent in dystrophic (MDX) mouse skeletal muscle. Dev Biol 148: 314-321.
39. Charge SB, Rudnicki MA, (2004) Cellular and molecular regulation of muscle regeneration. Physiol Rev 84: 209-238.
40. Seale P, Sabourin LA, Girgis-Gabardo A, Mansouri A, Gruss P, et al. (2000) Pax7 is required for the specification of myogenic satellite cells. Cell 102: 777-786.
41. Burkin DJ, Kaufman SJ, (1999) The alpha7beta1 integrin in muscle development and disease. Cell Tissue Res 296: 183-190.
42. Kim MH, Kay DI, Rudra RT, Chen BM, Hsu N, et al. (2011) Myogenic Akt signaling attenuates muscular degeneration, promotes myofiber regeneration and improves muscle function in dystrophin-deficient mdx mice. Hum Mol Genet 20: 1324-1338.
43. Hindi SM, Tajrishi MM, Kumar A, (2013) Signaling mechanisms in Mammalian myoblast fusion. Sci Signal 6: re2.
44. Blake DJ, Weir A, Newey SE, Davies KE, (2002) Function and genetics of dystrophin and dystrophin-related proteins in muscle. Physiol Rev 82: 291-329.
45. Dalkilic I, Kunkel LM, (2003) Muscular dystrophies: genes to pathogenesis. Curr Opin Genet Dev 13: 231-238.
46. Emery AE, (2002) The muscular dystrophies. Lancet 359: 687-695.
47. Heslop L, Morgan JE, Partridge TA, (2000) Evidence for a myogenic stem cell that is exhausted in dystrophic muscle. J Cell Sci 113 (Pt 12): 2299-2308.
48. Irintchev A, Zweyer M, Wernig A, (1997) Impaired functional and structural recovery after muscle injury in dystrophic mdx mice. Neuromuscul Disord 7: 117-125.
49. Itagaki Y, Saida K, Iwamura K, (1995) Regenerative capacity of mdx mouse muscles after repeated applications of myo-necrotic bupivacaine. Acta Neuropathol 89: 380-384.
50. Bockhold KJ, Rosenblatt JD, Partridge TA, (1998) Aging normal and dystrophic mouse muscle: analysis of myogenicity in cultures of living single fibers. Muscle Nerve 21: 173-183.
51. Duance VC, Stephens HR, Dunn M, Bailey AJ, Dubowitz V, (1980) A role for collagen in the pathogenesis of muscular dystrophy? Nature 284: 470-472.
52. Alexakis C, Partridge T, Bou-Gharios G, (2007) Implication of the satellite cell in dystrophic muscle fibrosis: a self-perpetuating mechanism of collagen overproduction. Am J Physiol Cell Physiol 293: C661-669.
53. Spate U, Schulze PC, (2004) Proinflammatory cytokines and skeletal muscle. Curr Opin Clin Nutr Metab Care 7: 265-269.
54. Li H, Malhotra S, Kumar A, (2008) Nuclear factor-kappa B signaling in skeletal muscle atrophy. J Mol Med 86: 1113-1126.
55. Baeg GH, Perrimon N, (2000) Functional binding of secreted molecules to heparan sulfate proteoglycans in Drosophila. Curr Opin Cell Biol 12: 575-580.
56. Betz W, Sakmann B, (1973) Effects of proteolytic enzymes on function and structure of frog neuromuscular junctions. J Physiol 230: 673-688.
57. Dunaevsky A, Connor EA, (1998) Stability of frog motor nerve terminals in the absence of target muscle fibers. Dev Biol 194: 61-71.
58. Vracko R, Benditt EP, (1972) Basal lamina: the scaffold for orderly cell replacement. Observations on regeneration of injured skeletal muscle fibers and capillaries. J Cell Biol 55: 406-419.
59. Alameddine HS, (2012) Matrix metalloproteinases in skeletal muscles: friends or foes? Neurobiol Dis 48: 508-518.
60. Carmeli E, Moas M, Reznick AZ, Coleman R, (2004) Matrix metalloproteinases and skeletal muscle: a brief review. Muscle Nerve 29: 191-197.
61. Kuang S, Rudnicki MA, (2008) The emerging biology of satellite cells and their therapeutic potential. Trends Mol Med 14: 82-91.
62. Guo LY, Li YM, Qiao L, Liu T, Du YY, et al. (2012) Notch2 regulates matrix metallopeptidase 9 via PI3K/AKT signaling in human gastric carcinoma cell MKN-45. World J Gastroenterol 18: 7262-7270.
63. von Maltzahn J, Renaud JM, Parise G, Rudnicki MA, (2012) Wnt7a treatment ameliorates muscular dystrophy. Proc Natl Acad Sci U S A 109: 20614-20619.
64. Katoh M, Katoh M, (2007) WNT signaling pathway and stem cell signaling network. Clin Cancer Res 13: 4042-4045.
65. Kofler NM, Shawber CJ, Kangsamaksin T, Reed HO, Galatioto J, et al. (2011) Notch signaling in developmental and tumor angiogenesis. Genes Cancer 2: 1106-1116.
66. Parker MH, Loretz C, Tyler AE, Duddy WJ, Hall JK, et al. (2012) Activation of Notch signaling during ex vivo expansion maintains donor muscle cell engraftment. Stem Cells 30: 2212-2220.